Biogen Medical Research
Ophthalmology
Scientific Objectives
We are currently only accepting proposals from the United States.
The following areas of research are currently being considered:
Geographic Atrophy (GA)
- Development of studies and tests to evaluate visual function in patients with GA due to AMD
- Further understanding of the relationship between GA and neovascularization in AMD
- Real world effectiveness of pegcetacoplan in patients with GA due to AMD
- Effectiveness and safety of pegcetacoplan in patients with GA due to AMD with clinical features (phenotypes) not assessed in clinical trials (including but not limited to bilateral GA patients treated in both eyes; GA patients with lesions approximately 200 microns or further from the foveal center)
- Effectiveness and safety of pegcetacoplan in GA due to AMD with different dosing intervals and dose escalation or de-escalation
- Further understanding of biomarkers in GA to assess disease progression and/or treatment response
Note to applicants outside the US: All proposals for systemic pegcetacoplan research to be conducted outside the US should be submitted to Sobi.
Research support is awarded on a highly competitive basis, and submission of research proposals in these areas of interest does not guarantee support will be awarded.